BC

Bhupendra Chandrakant Mhatre

Active Director Director DIN 10348279
DIN 10348279 First appointment Oct 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhupendra Chandrakant Mhatre

Data last updated:

Bhupendra Chandrakant Mhatre is a Director at Swati Nova Laboratories Private Limited (since 2023). The company operates in Pharma.

DIN 10348279
Primary Designation Director
Industry Pharma
First Appointment 10 Oct 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Oct 20232023Active

Board colleagues of Bhupendra Chandrakant Mhatre

NameDINCompanyDesignation
Duvvuri Radha Rani06823885Swati Nova Laboratories Private LimitedDirector

Directorship timeline

Open interactive timeline →
Swati Nova Laboratories Private Limited
Premium access

Shareholding and investment profile for Bhupendra Chandrakant Mhatre

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhupendra Chandrakant Mhatre

Bhupendra Chandrakant Mhatre currently holds 1 directorship: Swati Nova Laboratories Private Limited (Director, since 10 Oct 2023).

Bhupendra Chandrakant Mhatre was first appointed on 10 Oct 2023 as Director at Swati Nova Laboratories Private Limited.

The current boards of Bhupendra Chandrakant Mhatre's companies include Duvvuri Radha Rani (Swati Nova Laboratories Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available